SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950124-02-002751
Filing Date
2002-08-14
Accepted
2002-08-14 15:20:49
Documents
6
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR QUARTER ENDED JUNE 30, 2002 k71021e10vq.txt 10-Q 63481
3 1998 STOCK OPTION PLAN k71021exv10w42.txt EX-10.42 27709
4 2000 EQUITY COMPENSATION PLAN k71021exv10w43.txt EX-10.43 46584
5 EMPLOYMENT ARRANGEMENT - WILLIAM F. BRINKERHOFF k71021exv10w44.txt EX-10.44 5445
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 k71021exv99w1.txt EX-99.1 946
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 k71021exv99w2.txt EX-99.2 956
  Complete submission text file 0000950124-02-002751.txt   147387
Mailing Address 3621 STATE STREET 695 KMS PLACE ANN ARBOR MI 48108
Business Address 3621 S STATE STREET 695KMS PLACE 734-332-0506 ANN ARBOR MI 48108
ESPERION THERAPEUTICS INC/MI (Filer) CIK: 0001066745 (see all company filings)

IRS No.: 383419139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16033 | Film No.: 02735659
SIC: 2834 Pharmaceutical Preparations